Abstract
In an age of modern technology and an increasing movement towards a 24-h working culture, life for many is becoming more stressful and demanding. To help juggle these work commitments and an active social life, nootropic medication, (the so-called ‘smart pills’) have become a growing part of some people’s lives. Users claim that these drugs allow them to reach their maximal potential by becoming more efficient, smarter and requiring less sleep. The use of these medications and the role of health professionals in their distribution raises many ethical questions.
References
British Medical Association, BMA. (2007). Boosting your brainpower: Ethical aspects of cognitive enhancements. London, UK: British Medical Association.
Caldwell, J.A., J.L. Caldwell, N.K. Smythe, and K.K. Hall. 2000. A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: A helicopter simulator study. Psychopharmacology (Berl) 150: 272–282.
Chatterjee, A. 2004. Cosmetic neurology: The controversy over enhancing movement, mentation, and mood. Neurology 63: 968–974.
CMA. 1995. The role of physicians in prevention and health promotion. Canadian Medical Association. Canadian Medical Association Journal (CMAJ) 153: 208A–208D.
Larriviere, D., M. Williams, M. Rizzo, and R.J. Bonnie. 2009. Responding to requests from adult patients for neuroenhancements: Guidance of the Ethics, Law and Humanities Committee. Neurology 73: 1406–1412. doi:10.1212/WNL.0b013e3181beecfe.
Repantis, D., O. Laisney, and I. Heuser. 2010a. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research the Official Journal of the Italian Pharmacological Society 61: 473–481.
Repantis, D., P. Schlattmann, O. Laisney, and I. Heuser. 2010b. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research the Official Journal of the Italian Pharmacological Society 62: 187–206.
Repantis, D., P. Schlattmann, O. Laisney, and I. Heuser. 2008. Antidepressants for neuroenhancement in healthy individuals: A systematic review. Poiesis Praxis 6: 139–174. doi:10.1007/s10202-008-0060-4.
Talbot, M. (2009) Brain gain: The underworld of neuroenhancing drugs. The New Yorker. http://www.newyorker.com/reporting/2009/04/27/090427fa_fact_talbot. Accessed June 2013.
Turner, D.C., T.W. Robbins, L. Clark, et al. 2003. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 165: 260–269.
Yesavage, J.A., M.S. Mumenthaler, J.L. Taylor, et al. 2002. Donepezil and flight simulator performance: Effects on retention of complex skills. Neurology 59: 721.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Muhammed, K. Cosmetic neurology: the role of healthcare professionals. Med Health Care and Philos 17, 239–240 (2014). https://doi.org/10.1007/s11019-013-9497-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11019-013-9497-x